Vol 73, No 4 (2022)
Review article
Submitted: 2022-12-05
Accepted: 2022-12-15
Published online: 2022-12-28
Get Citation

There’s something in the water: an overview of jellyfish, their stings, and treatment

Emma P. DeLoughery1
·
Pubmed: 36583407
·
IMH 2022;73(4):199-202.
Affiliations
  1. Oregon Health and Science University, Portland, OR, United States
Vol 73, No 4 (2022)
TROPICAL MEDICINE Review article
Submitted: 2022-12-05
Accepted: 2022-12-15
Published online: 2022-12-28

Abstract

An increasing presence on many beaches worldwide, jellyfish are a diverse group of Cnidarians equipped
with stinging cells termed cnidocytes. Though few of the over 10,000 species are dangerous to humans,
and most that are produce no more than a painful sting, some jellyfish can produce systemic symptoms
and even death. Chironex fleckeri, the Australian box jellyfish, has a venom potent enough to kill in less
than 10 minutes, and for which there is an antivenom of debatable efficacy. Stings from Carukia barnesi
can cause Irukandji syndrome, characterised by severe pain and hypertension. Jellyfish stings have also
been associated with Guillain-Barre syndrome and anaphylaxis. Though optimal treatment of stings remains
controversial, after removal from the water and addressing any immediate life threats, the tentacles should
be removed and the area washed, with seawater being the best choice due to its low likelihood of inducing
further cnidocyte discharge. Hot water immersion may be beneficial for pain control for non-tropical jellyfish
stings, and cold packs for tropical stings. In general, there is no consensus for the optimal treatment
of jellyfish stings, and so further research is needed into species-specific guidelines and whether there
are any overarching rules.

Abstract

An increasing presence on many beaches worldwide, jellyfish are a diverse group of Cnidarians equipped
with stinging cells termed cnidocytes. Though few of the over 10,000 species are dangerous to humans,
and most that are produce no more than a painful sting, some jellyfish can produce systemic symptoms
and even death. Chironex fleckeri, the Australian box jellyfish, has a venom potent enough to kill in less
than 10 minutes, and for which there is an antivenom of debatable efficacy. Stings from Carukia barnesi
can cause Irukandji syndrome, characterised by severe pain and hypertension. Jellyfish stings have also
been associated with Guillain-Barre syndrome and anaphylaxis. Though optimal treatment of stings remains
controversial, after removal from the water and addressing any immediate life threats, the tentacles should
be removed and the area washed, with seawater being the best choice due to its low likelihood of inducing
further cnidocyte discharge. Hot water immersion may be beneficial for pain control for non-tropical jellyfish
stings, and cold packs for tropical stings. In general, there is no consensus for the optimal treatment
of jellyfish stings, and so further research is needed into species-specific guidelines and whether there
are any overarching rules.

Get Citation

Keywords

jellyfish, venoms, marine envenomation

About this article
Title

There’s something in the water: an overview of jellyfish, their stings, and treatment

Journal

International Maritime Health

Issue

Vol 73, No 4 (2022)

Article type

Review article

Pages

199-202

Published online

2022-12-28

Page views

3956

Article views/downloads

660

DOI

10.5603/IMH.2022.0034

Pubmed

36583407

Bibliographic record

IMH 2022;73(4):199-202.

Keywords

jellyfish
venoms
marine envenomation

Authors

Emma P. DeLoughery

References (17)
  1. Lakkis NA, Maalouf GJ, Mahmassani DM. Jellyfish stings: a practical approach. Wilderness Environ Med. 2015; 26(3): 422–429.
  2. Premmaneesakul H, Sithisarankul P. Toxic jellyfish in Thailand. Int Marit Health. 2019; 70(1): 22–26.
  3. Ryan RYM, Seymour J, Loukas A, et al. Immunological responses to envenomation. Front Immunol. 2021; 12: 661082.
  4. Pereira JC, Szpilman D, Haddad Junior V. Anaphylactic reaction/angioedema associated with jellyfish sting. Rev Soc Bras Med Trop. 2018; 51(1): 115–117.
  5. Montgomery L, Seys J, Mees J. To pee, or not to pee: a review on envenomation and treatment in European jellyfish species. Mar Drugs. 2016; 14(7).
  6. Suriyan S, Haruethaikan K, Piyachat RE. A survey of jellyfish sting knowledge among Thai divers in Thailand. Int Marit Health. 2019; 70(1): 11–16.
  7. Kong EL, Nappe TM. Irukandji Syndrome. StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
  8. Ames CL, Klompen AML, Badhiwala K, et al. Cassiosomes are stinging-cell structures in the mucus of the upside-down jellyfish Cassiopea xamachana. Commun Biol. 2020; 3(67).
  9. Tibballs J, Yanagihara AA, Turner HC, et al. Immunological and toxinological responses to jellyfish stings. Inflamm Allergy Drug Targets. 2011; 10(5): 438–446.
  10. Mao C, Hsu CC, Chen KT. Ocular Jellyfish Stings: Report of 2 Cases and Literature Review. Wilderness Environ Med. 2016; 27(3): 421–424.
  11. Amato G, Vita F, Gemelli F, et al. Jellyfish anaphylaxis: A wide spectrum of sensitization routes. Allergy Asthma Proc. 2020; 41(3): 158–166.
  12. Tibballs J, Li R, Tibballs HA, et al. Australian venomous jellyfish, envenomation syndromes, toxins and therapy. Toxicon. 2006; 48(7): 830–859.
  13. Cegolon L, Heymann WC, Lange JH, et al. Jellyfish stings and their management: a review. Mar Drugs. 2013; 11(2): 523–550.
  14. Remigante A, Costa R, Morabito R, et al. Impact of scyphozoan venoms on human health and current first aid options for stings. Toxins (Basel). 2018; 10(4).
  15. Doyle TK, Headlam JL, Wilcox CL, et al. Evaluation of cyanea capillata sting management protocols using ex vivo and in vitro envenomation models. Toxins (Basel). 2017; 9(7).
  16. Yanagihara AA, Wilcox CL. Cubozoan sting-site seawater rinse, scraping, and ice can increase venom load: upending current first aid recommendations. Toxins (Basel). 2017; 9(3): 105.
  17. Honeycutt JD, Jonas CE, Smith RF. FPIN's clinical inquiries: treatment of jellyfish envenomation. Am Fam Physician. 2014; 89(10): Online.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl